Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,211 | 20,618 | 16,577 | 24,789 | 56,360 |
| Marketable Securities | 156,362 | 188,740 | 193,507 | 193,676 | 164,062 |
| Receivables | 8,959 | 10,417 | 12,841 | 13,978 | 13,004 |
| Income taxes - deferred | N/A | N/A | N/A | 1,147 | 1,581 |
| TOTAL | $190,591 | $224,065 | $232,156 | $241,790 | $242,665 |
| Non-Current Assets | |||||
| PPE Net | 8,526 | 8,306 | 8,004 | 7,499 | 7,691 |
| Investments And Advances | 65,330 | 35,037 | 32,119 | 26,194 | 25,224 |
| Other Non-Current Assets | 14,511 | 10,971 | 8,998 | 6,451 | 6,015 |
| TOTAL | $88,367 | $54,314 | $49,121 | $40,144 | $38,930 |
| Total Assets | $278,958 | $278,379 | $281,277 | $281,934 | $281,595 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,056 | 1,952 | 3,377 | 2,044 | 2,572 |
| Accrued Expenses | 5,098 | 4,479 | 4,512 | 4,583 | 2,632 |
| TOTAL | $9,154 | $6,431 | $7,889 | $9,569 | $11,988 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,793 | 3,780 | 3,452 | 3,358 | 3,192 |
| TOTAL | $3,793 | $3,780 | $3,452 | $3,358 | $3,192 |
| Total Liabilities | $12,947 | $10,211 | $11,341 | $12,927 | $15,180 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,084 | 19,041 | 19,039 | 19,036 | 18,957 |
| Common Shares | 191 | 190 | 190 | 190 | 190 |
| Retained earnings | 17,274 | 22,666 | 27,646 | 29,448 | 30,524 |
| Other shareholders' equity | -108 | -85 | 19 | 117 | 201 |
| TOTAL | $266,011 | $268,168 | $269,936 | $269,007 | $266,415 |
| Total Liabilities And Equity | $278,958 | $278,379 | $281,277 | $281,934 | $281,595 |